Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 59,882 shares at $35.38 ($2.1M) on 2024-10-02, disclosed to the SEC on 2024-10-03.
Scheduled sale ($2.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.16 | 8,423 | $296K | 14.0% |
| 2 | $35.16 | 8,423 | $296K | 14.0% |
| 3 | $35.38 | 21,518 | $761K | 36.0% |
| 4 | $35.38 | 21,518 | $761K | 36.0% |
| Total | $35.32 avg | 59,882 | $2.1M | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |